Chronic portal vein thrombosis (PVT) presents a distinct management challenge when it occurs alongside underlying thrombophilia, when there is extension into the mesenteric veins, or when the clinical picture includes bowel ischemia. Each of these features shifts the risk–benefit calculus and shapes the treatment decision.
This evidence-based regimen addresses chronic PVT in select patients — specifically those with a documented thrombophilia, those whose thrombosis extends to involve the mesenteric veins, and those presenting with bowel ischemia. Per ACG guidance, anticoagulation in chronic PVT is not universally recommended; it is reserved for this subset of patients.
DOI: 10.1016/j.tvir.2025.101084
View source ↗